The 2023 Belgian clinical guidance on anticoagulation management in hospitalized and ambulatory COVID-19 patients
Description
COVID-19 is associated with an increased risk for thrombotic complications. The trials investigating the optimal thromboprophylactic dose are performed in challenging times and seemingly produce conflicting evidence. The burdensome circumstances
